Intron A

interferon alfa-2b

Drug timelines are a Plus or Pro feature.

22 regulatory and trial events tracked for Intron A, covering 2006-05-09 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients [Phase 1, Phase 2]